Literature DB >> 9261359

A splicing enhancer in the 3'-terminal c-H-ras exon influences mRNA abundance and transforming activity.

D Y Hwang1, J B Cohen.   

Abstract

Analysis of cDNA clones previously identified an optional intron in the 3'-untranslated region of the human H-ras gene. A possible correlation was observed between failure to remove this intron and overexpression of the gene, suggesting that splicing of the intron may require a specific titrable factor. The splicing signals at the end of the intron deviate from the consensus and may be inefficient, but we noticed that the adjacent exon downstream has a purine-rich region reminiscent of purine-rich splicing enhancers in other genes that stimulate the removal of weak, flanking introns. We show here that the purine-rich region of H-ras has splicing-enhancer activity in the homologous as well as a heterologous context. Interestingly, although the affected intron is outside the coding region, inversion or deletion of the enhancer reduced the transforming activity of oncogenic H-ras alleles severalfold. Experiments with corresponding cDNA constructs suggested that this is not a consequence of the altered structures of the mRNAs produced when the enhancer is inverted or deleted. Instead, we propose that the region controls an additional pre-mRNA processing event besides splicing of the terminal intron. Our work indicates that the purine-rich region may play an important role in the control of H-ras activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261359      PMCID: PMC191915     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Mechanism of transduction by retroviruses.

Authors:  A Swain; J M Coffin
Journal:  Science       Date:  1992-02-14       Impact factor: 47.728

2.  Cloning and domain structure of the mammalian splicing factor U2AF.

Authors:  P D Zamore; J G Patton; M R Green
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

Review 3.  Biochemical mechanisms of constitutive and regulated pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Cell Biol       Date:  1991

4.  Selection of splice sites in pre-mRNAs with short internal exons.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

5.  A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.

Authors:  J M Yeakley; J P Morfin; M G Rosenfeld; X D Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

7.  Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy
Journal:  Science       Date:  1983-06-03       Impact factor: 47.728

8.  Positive control of pre-mRNA splicing in vitro.

Authors:  M Tian; T Maniatis
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

9.  Regulation of doublesex pre-mRNA processing occurs by 3'-splice site activation.

Authors:  L C Ryner; B S Baker
Journal:  Genes Dev       Date:  1991-11       Impact factor: 11.361

10.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

View more
  5 in total

1.  An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus.

Authors:  L M McNally; M T McNally
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes.

Authors:  N Kienzle; D B Young; D Liaskou; M Buck; S Greco; T B Sculley
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells.

Authors:  G W Kemble; P Annunziato; O Lungu; R E Winter; T A Cha; S J Silverstein; R R Spaete
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally.

Authors:  Mark Steven Miller; Lance D Miller
Journal:  Front Genet       Date:  2012-01-03       Impact factor: 4.599

5.  Irf3 polymorphism alters induction of interferon beta in response to Listeria monocytogenes infection.

Authors:  Oleg Garifulin; Zanmei Qi; Haihong Shen; Sujatha Patnala; Michael R Green; Victor Boyartchuk
Journal:  PLoS Genet       Date:  2007-07-20       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.